Episode
ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders
- Podcast
- Breast Cancer Update
- Published
- Nov 5, 2025
- Duration seconds
- 2477
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/er-positive-metastatic-breast-cancer-an-interview-with-prof-patrick-neven-on-the-role-of-oral-selective-estrogen-receptor-degraders/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/breast-cancer-update-757579/er-positive-metastatic-breast-cancer-an-interview-with-prof-patrick-neven-on-the-role-of-oral-selective-estrogen-receptor-degraders.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Prof Patrick Neven from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies with oral SERDs for ER-positive metastatic breast cancer. CME information and select publications here .